Use of non-antiretroviral drugs among individuals with and without HIV-infection: a Danish nationwide study
暂无分享,去创建一个
[1] M. May,et al. Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study. , 2015, The lancet. HIV.
[2] R. Cooper,et al. Managing drug interactions in HIV-infected adults with comorbid illness , 2015, Canadian Medical Association Journal.
[3] G. Kronborg,et al. Utilization of psychotropic drugs prescribed to persons with and without HIV infection: a Danish nationwide population‐based cohort study , 2014, HIV medicine.
[4] O. Kirk,et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration , 2014, The Lancet.
[5] V. Valcour,et al. Polypharmacy, Drug–Drug Interactions, and Potentially Inappropriate Medications in Older Adults with Human Immunodeficiency Virus Infection , 2014, Journal of the American Geriatrics Society.
[6] J. Raboud,et al. Association of Age With Polypharmacy and Risk of Drug Interactions With Antiretroviral Medications in HIV-Positive Patients , 2013, The Annals of pharmacotherapy.
[7] J. Glover,et al. The Next Therapeutic Challenge in HIV: Polypharmacy , 2013, Drugs & Aging.
[8] I. Grant,et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. , 2013, AIDS patient care and STDs.
[9] J. Nachega,et al. Antiretroviral therapy adherence and drug–drug interactions in the aging HIV population , 2012, AIDS.
[10] M. Gill,et al. Pill Burden in HIV Infection: 20 Years of Experience , 2012, Antiviral therapy.
[11] W. Gellad,et al. Medication adherence to multidrug regimens. , 2012, Clinics in geriatric medicine.
[12] T. Bärnighausen,et al. HIV and aging--preparing for the challenges ahead. , 2012, The New England journal of medicine.
[13] A. Carballo-Diéguez,et al. Depressive Symptoms Among MSM Who Engage in Bareback Sex: Does Mood Matter? , 2012, AIDS and Behavior.
[14] A. Roverato,et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] R. Weber,et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] R. Weber,et al. Ageing with HIV: medication use and risk for potential drug-drug interactions. , 2011, The Journal of antimicrobial chemotherapy.
[17] C. Pedersen,et al. The Danish Civil Registration System , 2011, Scandinavian journal of public health.
[18] C. Larsen,et al. Adherence to national guidelines for initiation of antiretroviral regimens in HIV patients: a Danish nationwide study. , 2011, British journal of clinical pharmacology.
[19] J. Hallas,et al. The Danish National Prescription Registry , 2011, Scandinavian journal of public health.
[20] R. Weber,et al. Prevalence of comedications and effect of potential drug–drug interactions in the Swiss HIV Cohort Study , 2010, Antiviral therapy.
[21] H. Sørensen,et al. Cohort profile: the Danish HIV cohort study. , 2009, International journal of epidemiology.
[22] A. Justice,et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] P. Volberding,et al. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. , 2007, Journal of the American Society of Nephrology : JASN.
[24] Mridula Nair,et al. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable , 2007, Expert opinion on drug safety.
[25] J Darbyshire,et al. CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.
[26] O. Kirk,et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. , 2006, Archives of internal medicine.
[27] S. Jensen-Fangel,et al. Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort Study , 2005, Scandinavian journal of infectious diseases.
[28] Stephen H. D. Jackson,et al. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. , 2003, British journal of clinical pharmacology.
[29] R. Kessler,et al. Risk of psychiatric disorders among individuals reporting same-sex sexual partners in the National Comorbidity Survey. , 2001, American journal of public health.
[30] O Pelkonen,et al. Age and cytochrome P450‐linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions , 1997, Clinical pharmacology and therapeutics.
[31] B. Thiers,et al. CD4+ Count–Guided Interruption of Antiretroviral Treatment , 2007 .
[32] R. de Graaf,et al. Same-sex sexual behavior and psychiatric disorders: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). , 2001, Archives of general psychiatry.
[33] J. Hallas,et al. PHARMACOEPIDEMIOLOGY AND PRESCRIPTION , 1997 .
[34] Organización Mundial de la Salud. Guidelines for ATC classification and DDD assignment , 1996 .